ArticleParkinson's disease2022

Collective Expert Perspectives on the Use of Safinamide as Adjunctive Therapy for Parkinson's Disease: Online-Based Delphi Survey.

Atsushi Takeda et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.